Dr. Kamal Rahimizadeh is a post-doctoral scientist in the Precision Nucleic Acid Therapeutics Group led by Associate Professor Rakesh Veedu in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT) at Murdoch University. He is focused on aptamer development and related diagnostic and therapeutic applications, including Tissue-specific Aptamers for delivering therapeutic nucleic acids and rapid diagnostic test.
Molecular Therapy - Nucleic Acids. 19:190-198. DOI: 10.1016/j.omtn.2019.11.004
Development of cell-specific aptamers: Recent advances and insight into the selection procedures (2017)
Molecules. 22(12) DOI: 10.3390/molecules22122070
Synthesis of a Morpholino Nucleic Acid (MNA)-uridine phosphoramidite, and exon skipping using MNA/2′-O-methyl mixmer antisense oligonucleotide (2016)
Molecules. 21(11) DOI: 10.3390/molecules21111582